Evgen Pharma granted first European patent for SFX-01
Theracryf
0.80p
16:49 26/04/24
0.00%
0.00p
Clinical-stage drug development company Evgen Pharma announced the grant of the first European patent for SFX-01, its lead product, on Wednesday.
FTSE AIM All-Share
755.28
17:14 26/04/24
n/a
n/a
Pharmaceuticals & Biotechnology
22,773.26
16:59 26/04/24
0.10%
22.78